Cancer
is one of the most prevalent fatal chronic disorders with a high
mortality rate due to its extremely invasive nature and prolonged
duration of disease. Bone cancer is a type of cancer in which the
bone tissues grows in an uncontrollable manner. This growth may be
benign or malignant. In most cases bone cancer results from other
cancers such as lung cancer, kidney cancer, prostate cancer, and
breast cancer, which is also called secondary or metastatic bone
cancer. The major and primary symptom of bone cancer is severe bone
pain, which usually intensifies with time. In addition to pain,
symptoms such as weight loss, fever, fatigue, muscle pain, bone
crack, osteoporosis and osteopenia are also identified. Diagnosis of
bone cancer includes understanding patient’s history and reasons
causing pain. Besides, bone cancer can be diagnosed using imaging
techniques such as computerized tomography (CT), bone scan, magnetic
resonance imaging (MRI), positron emission tomography (PET) scanning,
and biopsy tests.
For
In-Depth Review | Get Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/93
Bone
cancer treatment market can be classified on basis of type and
treatment available for bone cancer
The
bone cancer treatment market is analyzed on the basis of type of bone
cancer into primary bone cancer and secondary bone cancer. Primary
bone cancer originates from fast and uncontrollable growth of the
bone and other related tissues. Types of primary bone cancer include
osteosarcoma, chondrosarcoma, Ewing’s sarcoma, spindle cell
sarcoma, and chordoma. Secondary bone cancer, also called metastatic
bone cancer, arises due to spreading of cancer cells from different
parts of body. It is also referred as metastatic bone cancer.
On
the basis of therapies or treatments available, the global bone
cancer treatment market is classified as radiation therapy,
chemotherapy, cryosurgery, and surgical treatments. The major
surgical practices used to treat bone cancer are limb amputation
surgery and limb salvage surgery or limb sparing surgery. In
radiation therapy, high energy X-rays or gamma-rays are used to
destroy tumors. Chemotherapy is a pharmacological treatment that
involves the use of anti-cancer drugs. Major drugs include
strontium-89 chloride, bisphosphonates, methotrexate, and
doxorubicin, among others. Cryosurgery is sometimes used in lieu of
conventional surgery to kill tumors.
Increasing
disease incidence creating favorable growth environment for Bone
cancer treatment market
Developed
markets such as the U.S., U.K., Japan, Canada, Australia, Germany,
and Spain have a robust healthcare infrastructure that provides
patients with easy access to advanced healthcare facilities, which
aids in early diagnosis of bone cancer. According to the American
Cancer Society (ACS), approximately 3,300 new cases of bone cancer
are expected to be diagnosed in 2016, resulting in around 1,490
deaths in the same year. Moreover, the ACS sates that in adults over
40% of primary bone cancers are chondrosarcomas. This is followed by
osteosarcomas (28%), chordomas (10%), Ewing tumors (8%), and
malignant fibrous histiocytoma/fibrosarcomas (4%). According to 2016
Cancer.Net estimates, 3,300 people of all ages in the U.S. would be
diagnosed with primary bone cancer. New cases of bone cancer being
diagnosed would propel growth of the bone cancer treatment market in
the U.S. On the other hand, rising incidence rate in Asia Pacific is
expected to be a major growth factor for the global bone cancer
treatment market, supported by growing awareness among the populace.
Global
players involved in the bone cancer treatment market
Major
players involved in bone cancer treatment market include Amgen Inc.,
Actavis plc, Novartis International AG, Debiopharm Group, Pfizer,
Inc., and Eli Lilly and Company.
Dr.
Andre Roodt, a researcher at the University of Free State has
developed pain relieving drug for bone cancer patients in December
2016. The drug is a liquid radioactive isotope that can detect cancer
in the body. Innovation in treatment options would lead to better
therapeutic outcomes.
Browse
Complete Research Report @
https://www.coherentmarketinsights.com/ongoing-insight/bone-cancer-treatment-market-93
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment